Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV

Arteriovenous malformations of the brain: natural history in unoperated patients.

Crawford, P. M., West, C. R., Chadwick, D. W., & Shaw, M. D. M. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.1.1 · Cited by 814

Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study

Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662

Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases

Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1988) · Annals of Neurology · doi:10.1002/ana.410240110 · Cited by 362

Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity.

Gasset, M., Baldwin, M. A., Fletterick, R. J., & Prusiner, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.1 · Cited by 307

Pre‐and Postmortem Influences on Brain RNA

BARTON, A. J. L., Pearson, R. C. A., Najlerahim, A., & Harrison, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03532.x · Cited by 269

Clinicopathologic Studies of Primary Cerebral Amyloid Angiopathy

Okazaki, H., Reagan, T. J., & Campbell, R. J. (1979) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18993-3 · Cited by 259

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension.

Olichney, J. M., Hansen, L., Hofstetter, C., Grundman, M., Katzman, R., & Thal, L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 251

Evaluation of thermography in the diagnosis of selected entrapment neuropathies

So, Y. T., Olney, R. K., & Aminoff, M. J. (1989) · Neurology · doi:10.1212/wnl.39.1.1 · Cited by 171

Morphological and Biochemical Analyses of Amyloid Plaque Core Proteins Purified from Alzheimer Disease Brain Tissue

Roher, A. E., Palmer, K. C., Yurewicz, E. C., Ball, M. J., & Greenberg, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09834.x · Cited by 144

Immunocytochemical localization of estrogen-induced progestin receptors in guinea pig brain

Blaustein, J. D., King, J. C., Toft, D. O., & Turcotte, J. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90664-6 · Cited by 144

Are cerebrovascular factors involved in Alzheimer’s disease?

Kudo, T., Imaizumi, K., Tanimukai, H., Katayama, T., Sato, N., Nakamura, Y., Tanaka, T., Kashiwagi, Y., Jinno, Y., Tohyama, M., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00129-9 · Cited by 66

Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency

Tibolla, G., Norata, G. D., Meda, C., Arnaboldi, L., Uboldi, P., Piazza, F., Ferrarese, C., Corsini, A., Maggi, A. C., Vegeto, E., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.040 · Cited by 59

Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab

Sveikata, L., Charidimou, A., & Viswanathan, A. (2021) · Stroke · doi:10.1161/strokeaha.121.036873 · Cited by 61

The Association Between Vascular Risk Factor‐Mediating Medications and Cognition and Dementia Diagnosis in a Community‐Based Sample of African‐Americans

Richards, S. S., Emsley, C. L., Roberts, J., Murray, M. D., Hall, K. S., Gao, S., & Hendrie, H. C. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04777.x · Cited by 59

Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults

Agrawal, S., & Schneider, J. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100148 · Cited by 61

Changes in Brain β-Amyloid Deposition and Aquaporin 4 Levels in Response to AlteredAgrinExpression in Mice

Rauch, S. M., Huen, K. H. Y., Miller, M. C., Chaudry, H., Lau, M., Sanes, J. R., Johanson, C. E., Stopa, E. G., & Burgess, R. W. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823b0b12 · Cited by 59

Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease

Palacios, H. H., Yendluri, B. B., Parvathaneni, K., Shadlinski, V. B., Obrenovich, M. E., Leszek, J., Gokhman, D., Gąsiorowski, K., Bragin, V., & Aliev, G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480474 · Cited by 60

Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease

Liu, C., Yamazaki, Y., Heckman, M. G., Martens, Y. A., Jia, L., Yamazaki, A., Diehl, N. N., Zhao, J., Zhao, N., Deture, M. A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12104 · Cited by 59

Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents

Pallebage‐Gamarallage, M. M., Lam, V., Takechi, R., Galloway, S., Clark, K., & Mamo, J. C. L. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-117 · Cited by 57

Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis

Castellani, R. J., Smith, M. A., Perry, G., & Friedland, R. P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.019 · Cited by 57

Management of acute ischaemic stroke in patients with dementia

Šubic, A., Čermáková, P., Norrving, B. G., Winblad, B. G., von Euler, M., Kramberger, M. G., Eriksdotter, M., & Ptacek, S. G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12588 · Cited by 58

A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases

Scott, L. L., & Downing, T. G. (2017) · Toxins · doi:10.3390/toxins10010022 · Cited by 59

White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype

Bronge, L., Fernaeus, S., Blomberg, M. E., Ingelson, M., Lannfelt, L., Isberg, B., & Wahlund, L. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017107 · Cited by 58

Types of Cerebrovascular Lesions Associated with Severe Cerebral Amyloid Angiopathy in Alzheimer's Diseasea

Olichney, J., Ellis, R. J., Katzman, R., Sabbagh, M. N., & Hansen, L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48511.x · Cited by 57

Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA

Esiri, M. M., Chance, S. A., Joachim, C. L., Warden, D. R., Smallwood, A., Sloan, C., Christie, S., Wilcock, G. K., & Smith, A. D. (2014) · Brain Pathology · doi:10.1111/bpa.12221 · Cited by 56

Cerebral beta-amyloid angiopathy in aged squirrel monkeys.

Elfenbein, H. A., Rosen, R. F., Stephens, S. L., Switzer, R. C., Smith, Y., Paré, J., Mehta, P. D., Warzok, R., & Walker, L. C. (2007) · PubMed · doi:10.14670/hh-22.155 · Cited by 57

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype

Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T. M., Sulkava, R. O., Verkkoniemi, A., Rastas, S., Paetau, A. E., & Kiuru‐Enari, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00652.x · Cited by 57

Amyloid‐β‐induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype

Verbeek, M. M., Nostrand, W. E. V., Otte‐Höller, I., Wesseling, P., & de Waal, R. M. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06368.x · Cited by 57

Prevalence of cortical superficial siderosis in patients with cognitive impairment

Wollenweber, F. A., Buerger, K., Mueller, C., Ertl-Wagner, B., Malik, R., Dichgans, M., Linn, J., & Opherk, C. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7181-y · Cited by 53

Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid

Austin, S. A., & Katusic, Z. S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18822474 · Cited by 52

Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies?

Moghbel, M. C., Saboury, B., Basu, S. K., Metzler, S. D., Torigian, D. A., Långström, B., & Alavi, A. A. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1960-4 · Cited by 53

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers

Jang, H., Jang, Y. K., Kim, H. J., Werring, D. J., Lee, J. S., Choe, Y. S., Park, S., Lee, J., Kim, K. W., Kim, Y., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04314-7 · Cited by 50

Severe Cerebral Amyloid Angiopathy Characterizes an Underestimated Variant of Vascular Dementia

Haglund, M., Sjöbeck, M., & Englund, E. M. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000079192 · Cited by 51

Cerebral amyloid angiopathy and related inflammatory disorders

Chwalisz, B. K. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117425 · Cited by 53

Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice

Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Wellington, C. L., Johnsen, R. D., & Mamo, J. C. L. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0567-3 · Cited by 51

Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases

Aliev, G., Li, Y., Palacios, H. H., & Obrenovich, M. E. (2011) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489011797376942 · Cited by 51

Neurovascular Ageing and Age-Related Diseases

Kalaria, R. N., & Hase, Y. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_17 · Cited by 55

Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage

Jellinger, K. A., Lauda, F., & Attems, J. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01880.x · Cited by 52

FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness

Canepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 54

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

van Veluw, S. J., Kuijf, H. J., Charidimou, A., Viswanathan, A., Biessels, G. J., Rozemüller, A. J. M., Frosch, M. P., & Greenberg, S. M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1635-0 · Cited by 52

Dutch hereditary cerebral amyloid angiopathy: Structural lesions and apolipoprotein E genotype

Bornebroek, M., Haan, J., van Duinen, S. G., Maat–Schieman, M. L. C., van Buchem, M. A., Bakker, E., Broeckhoven, C. V., & Roos, R. A. C. (1997) · Annals of Neurology · doi:10.1002/ana.410410523 · Cited by 50

The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease

Mishra, P., Davies, D. A., & Albensi, B. C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03152-3 · Cited by 51

Methylene Blue Modulates β-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice

Mori, T., Koyama, N., Segawa, T., Maeda, M., Maruyama, N., Kinoshita, N., Hou, H., Tan, J., & Town, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568212 · Cited by 51

The Significance of Cortical Cerebellar Microbleeds and Microinfarcts in Neurodegenerative and Cerebrovascular Diseases

Reuck, J. L. D., Deramecourt, V., Auger, F., Durieux, N., Cordonnier, C., Devos, D., Defebvre, L., Moreau, C., Caparros-Lefebvre, D., Pasquier, F., et al. (2015) · Cerebrovascular Diseases · doi:10.1159/000371488 · Cited by 49

The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-β Levels: Resolubilization of amyloid-β with transition metal ion chelators

Fonte, J., Miklossy, J., Atwood, C., & Martins, R. N. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3206 · Cited by 49

Magnetic resonance imaging in dementia: a study of brain white matter changes

Bronge, L. (2002) · Acta Radiologica · doi:10.1034/j.1600-0455.43.s.428.1.x · Cited by 49

Developmental and amyloid plaque‐related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice

Kouznetsova, E., Klingner, M., Sorger, D., Sabri, O., Großmann, U., Steinbach, J., Scheunemann, M., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.011 · Cited by 49

Prevalence and Topography of Small Hypointense Foci Suggesting Microbleeds on 3T Susceptibility-Weighted Imaging in Various Types of Dementia

Uetani, H., Hirai, T., Hashimoto, M., Ikeda, M., Kitajima, M., Sakamoto, F., Utsunomiya, D., Oda, S., Sugiyama, S., Matsubara, J., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3332 · Cited by 48

The rise and fall of insulin signaling in Alzheimer’s disease

Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48

Epidemiology of Vascular Dementia

Leys, D., Pasquier, F., & Parnetti, L. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022425 · Cited by 49

Clinical, biological, and imaging features of monogenic Alzheimer’s disease

Pilotto, A., Padovani, A., & Borroni, B. (2013) · BioMed Research International · doi:10.1155/2013/689591 · Cited by 47

The cerebral circulation and cerebrovascular disease II: Pathogenesis of cerebrovascular disease

Geng, X., Chandra, A., Stone, C., Li, W., & Ding, Y. (2017) · Brain Circulation · doi:10.4103/bc.bc_11_17 · Cited by 47

Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation

Miller, J. H., Wardlaw, J. M., & Lammie, G. A. (1999) · Clinical Radiology · doi:10.1016/s0009-9260(99)90825-5 · Cited by 47

AGING AND CEREBROVASCULAR DISEASE

Choi, J. Y., Morris, J. C., & Hsu, C. Y. (1998) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70089-x · Cited by 47

Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

Alcendor, D. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051490 · Cited by 47

The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease

Pasquier, F., Leys, D., & Scheltens, P. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_11 · Cited by 46

Current pathophysiological concepts in cerebral small vessel disease

Rincón, F., & Wright, C. B. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00024 · Cited by 50

Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding

Shackleton, B., Crawford, F., & Bachmeier, C. J. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0038-x · Cited by 49

Amyloid PET imaging in clinical practice

Kolanko, M., Win, Z., Loreto, F., Patel, N., Carswell, C. J., Gontsarova, A., Perry, R. J., & Malhotra, P. (2020) · Practical Neurology · doi:10.1136/practneurol-2019-002468 · Cited by 47

Chylomicron amyloid-beta in the aetiology of Alzheimer's disease

Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., & Mamo, J. C. L. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.010 · Cited by 46

Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6T

Kara, F., van Dongen, E. S., Schliebs, R., van Buchem, M. A., de Groot, H. J. M., & Alia, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.055 · Cited by 44

Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and Management

Mekala, A., & Qiu, H. (2025) · Biomolecules · doi:10.3390/biom15050712 · Cited by 49

High Levels of Homocysteine Results in Cerebral Amyloid Angiopathy in Mice

Li, J.-G., & Praticò, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141101 · Cited by 43

Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer’s Disease

Samuraki, M., Matsunari, I., Yoshita, M., Shima, K., Noguchi‐Shinohara, M., Hamaguchi, T., Ono, K., & Yamada, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150274 · Cited by 44

Subclinical Brain Hemorrhages in Alzheimer's Disease: Evaluation by Magnetic Resonance T2*‐Weighted Images

NAKATA, Y., Shiga, K., Yoshikawa, K., Mizuno, T., Mori, S., Yamada, K., & Nakajima, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04813.x · Cited by 43

Glymphatic and meningeal lymphatic dysfunction in Alzheimer's disease: Mechanisms and therapeutic perspectives

Ding, J., Zhao, C., Hao, X., & Jiao, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70709 · Cited by 50

Cerebral amyloidal angiopathy—A disease with implications for neurology and psychiatry

Gahr, M., Nowak, D. A., Connemann, B. J., & Schönfeldt‐Lecuona, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.052 · Cited by 43

NEUROLOGICAL INFECTION AND INFLAMMATION

Bone, I. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034249 · Cited by 42

Microvasculopathy Is Associated With the Number of Cerebrovascular Lesions in Hereditary Cerebral Hemorrhage With Amyloidosis, Dutch Type

Natté, R., Vinters, H. V., Maat-Schieman, M. L. C., Bornebroek, M., Haan, J., Roos, R. A. C., & van Duinen, S. G. (1998) · Stroke · doi:10.1161/01.str.29.8.1588 · Cited by 41

Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

Miners, J. S., Palmer, J. C., Tayler, H. M., Palmer, L. E., Ashby, E. L., Kehoe, P. G., & Love, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00238 · Cited by 43

Prevention approaches in a preclinical canine model of Alzheimer’s disease: benefits and challenges

Davis, P. R., & Head, E. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00047 · Cited by 43

Can the retina be used to diagnose and plot the progression of Alzheimer's disease?

Mahajan, D., & Votruba, M. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13472 · Cited by 45

Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics

Sharma, R., Dearaugo, S., Infeld, B., O’Sullivan, R., & Gerraty, R. P. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12726 · Cited by 44

Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides

Tan, J., Town, T., Suo, Z., Wu, Y., Song, S., Kundtz, A., Kroeger, J. L., Humphrey, J., Crawford, F., & MULLAN, M. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00122-7 · Cited by 40

Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β‐amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain

Bürger, S., Noack, M., Kirazov, L., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 42

Plasma β‐Amyloid Peptide, Transforming Growth Factor‐β1, and Risk for Cerebral Amyloid Angiopathy

Greenberg, S. M., CHO, H., O’Donnell, H. C., Rosand, J. M., Segal, A. Z., Younkin, L. H., Younkin, S. G., & Rebeck, G. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06361.x · Cited by 42

Recent Aspects of Periodontitis and Alzheimer’s Disease—A Narrative Review

Cichońska, D., Mazuś, M., & Kusiak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052612 · Cited by 47

Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders

Romanucci, M., & Salda, L. D. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/940131 · Cited by 43

Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen

Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41

Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy

Donahue, J. E., Khurana, J. S., & Adelman, L. S. (1998) · Acta Neuropathologica · doi:10.1007/s004010050789 · Cited by 40

Differential recognition of vascular and parenchymal beta amyloid deposition

Rutgers, K. S., van Remoortere, A., van Buchem, M. A., Verrips, C. T., Greenberg, S. M., Bacskai, B. J., Frosch, M. P., van Duinen, S. G., Maat–Schieman, M. L. C., & van der Maarel, S. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.012 · Cited by 40

Prevalence and Effects of Lobar Microhemorrhages in Early-Stage Dementia

Atri, A., Locascio, J. J., Lin, J. M., Yap, L., Dickerson, B. C., Grodstein, F., Irizarry, M. C., Growdon, J. H., & Greenberg, S. M. (2005) · Neurodegenerative Diseases · doi:10.1159/000092317 · Cited by 40

Possible Link between Lipid Metabolism and Cerebral Amyloid Angiopathy in Alzheimer’s Disease: A Role for High-Density Lipoproteins?

Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40

Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab

Sveikata, L., Charidimou, A., & Viswanathan, A. (2022) · Archive ouverte UNIGE (University of Geneva) · Cited by 39

Dietary resveratrol supplementation normalizes gene expression in the hippocampus of streptozotocin-induced diabetic C57Bl/6 mice

Thomas, J., Garg, M. L., & Smith, D. W. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.005 · Cited by 40

α7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Aβ peptides and promotes cerebrovascular amyloid angiopathy

Clifford, P. M., Siu, G., Kosciuk, M. C., Levin, E. C., Venkataraman, V., D’Andrea, M. R., & Nagele, R. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.092 · Cited by 41

Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy

Cheng, X., He, P., Yao, H., Dong, Q., Li, R., & Shen, Y. (2014) · Neurology · doi:10.1212/wnl.0000000000000403 · Cited by 39

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease

Knight, M. J., McCann, B., Kauppinen, R. A., & Coulthard, E. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00139 · Cited by 41

Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease

Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 40

White Matter Changes and Poststroke Dementia

Leys, D., Hénon, H., & Pasquier, F. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051186 · Cited by 39

Neuropathological Assessment of Alzheimer’s Disease: The Experience of the Consortium to Establish a Registry for Alzheimer’s Disease

Mirra, S. S. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004985 · Cited by 39

Blood-Based Microcirculation Markers in Alzheimer's Disease–Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio

Büerger, K., Ernst, A. S., Ewers, M., Uspenskaya, O., Omerovic, M., Morgenthaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.032 · Cited by 38

Alzheimer's Disease, Genes, and Environment: The Value of International Studies

Hendrie, H., Hall, K., Ogunniyi, A., & Gao, S.-J. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900203 · Cited by 16

Isoform-specific vasoconstriction induced by Apolipoprotein E and modulation of this effect by Alzheimer's β-amyloid peptide

Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00764-2 · Cited by 38

Aβ Vasoactivity: An Inflammatory Reaction

Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06355.x · Cited by 38

Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological study

Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.11.005 · Cited by 39

Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages

Raposo, N., Planton, M., Péran, P., Payoux, P., Bonneville, F., Lyoubi, A., Albucher, J. F., Acket, B., Salabert, A., Olivot, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004228 · Cited by 36

Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype

Buciuc, M., Whitwell, J. L., Kasanuki, K., Graff‐Radford, J., Machulda, M. M., Duffy, J. R., Strand, E. A., Lowe, V. J., Graff‐Radford, N. R., Rush, B. K., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25979 · Cited by 37

Poststroke Dementia in the Elderly

Mackowiak‐Cordoliani, M., Bombois, S. P., Mémin, A., H�non, H., & Pasquier, F. (2005) · Drugs & Aging · doi:10.2165/00002512-200522060-00003 · Cited by 35

Neuroimaging of Vessel Amyloid in Alzheimer's Diseasea,b

Friedland, R. P., Kalaria, R. N., Berridge, M. S., Miraldi, F. D., Hedera, P., Reno, J. M., Lyle, L. R., & Marotta, C. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48475.x · Cited by 37

Mannan-Abeta28conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

Petrushina, I., Ghochikyan, A., Mkrtichyan, M., Mamikonyan, G., Movsesyan, N., Ajdari, R., Vasilevko, V., Karapetyan, A., Lees, A., Agadjanyan, M. G., et al. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-42 · Cited by 37

Role of Peroxynitrite in the Vasoactive and Cytotoxic Effects of Alzheimer's β-Amyloid1–40Peptide

Paris, D., Parker, T. A., Town, T., Suo, Z., Fang, C., Humphrey, J., Crawford, F., & MULLAN, M. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6828 · Cited by 37

Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds

Kim, Y. J., Kim, Y. J., Park, J., Kim, S., Woo, S., Kwak, K., Lee, J. M., Kim, Y. J., Kim, J. S., Choe, Y. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003220 · Cited by 36

Association of cortical microinfarcts and cerebral small vessel pathology in the ageing brain

Kövari, E., Herrmann, F. R., Gold, G., Hof, P. R., & Charidimou, A. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12366 · Cited by 36

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

Liao, C., Xu, J., Chen, Y., & Ip, N. Y. (2021) · Biomolecules · doi:10.3390/biom11081215 · Cited by 37

Prevalence and severity of cerebral amyloid angiopathy: a population‐based study on very elderly Finns (Vantaa 85+)

Tanskanen, M., Mäkelä, M. J., Myllykangas, L., Notkola, I. ‐., Polvikoski, T. M., Sulkava, R. O., Kalimo, H., & Paetau, A. E. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01219.x · Cited by 37

APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

Blackman, J., Love, S., Sinclair, L. I., Cain, R., & Coulthard, E. J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00992-y · Cited by 37

Hypertension, dementia, and antihypertensive treatment: Implications for the very elderly

Peters, R. K., & Beckett, N. S. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0047-0 · Cited by 35

Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration

Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 34

Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes

Hubin, E., Deroo, S., Schierle, G. S. K., Kaminski, C. F., Serpell, L. C., Subramaniam, V., van Nuland, N. A. J., Broersen, K., Raussens, V., & Sarroukh, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1983-2 · Cited by 36

O1–01–03: Alzheimer disease pathology influences the impact of cerebral amyloid angiopathy on cognitive decline

Quass, M., Attems, J., Jellinger, K. A., & Lintner, F. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.036

The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study

Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Maurage, C., & Pasquier, F. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03329.x · Cited by 64

＜Symposium IV＞Cerebral amyloid angiopathy and Alzheimer's disease

Ghiso, J. A., Tomidokoro, Y., Revez, T., Frangione, B., & Rostagno, A. A. (2010) · Institutional Repositories DataBase (IRDB)

The Impact of Cerebral Amyloid Angiopathy in Various Neurodegenerative Dementia Syndromes: A Neuropathological Study

Reuck, J. D. (2019) · Neurology Research International · doi:10.1155/2019/7247325 · Cited by 20

P1‐209: Cerebral amyloid angiopathy is not associated with late‐life cognitive performance in the honolulu asia aging study

Edland, S. D., Gelber, R. P., Zarow, C., Uyehara‐Lock, J. H., Sonnen, J. A., Montine, T. J., Launer, L. J., & White, L. R. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.409